{
    "clinical_study": {
        "@rank": "159858", 
        "arm_group": [
            {
                "arm_group_label": "Chlorhexidine", 
                "arm_group_type": "Experimental", 
                "description": "Washing of perineal area and proximal first 5 centimeters of catheter from mea, done by 15 ml of  Chlorhexidine 0.2%,  3 times a day for 10 days."
            }, 
            {
                "arm_group_label": "Povidone-Iodine", 
                "arm_group_type": "Experimental", 
                "description": "Washing of perineal area and proximal first 5 centimeters of catheter from mea, done by 15 ml of  Povidone-iodine 10%,  3 times a day for 10 days."
            }, 
            {
                "arm_group_label": "Normal saline", 
                "arm_group_type": "Active Comparator", 
                "description": "Washing of perineal area and proximal first 5 centimeters of catheter from mea, done by 15 ml of  Normal saline 0.9%,  3 times a day for 10 days."
            }
        ], 
        "brief_summary": {
            "textblock": "This study is conducted to determine and compare the effect of applying Povidone-iodine and\n      Chlorhexidine solutions for perinea washing on bacteriuria rate and type in patients with\n      urinary catheter in intensive care unit."
        }, 
        "brief_title": "Effect of Chlorhexidine on Bacteriuria", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Urinary Tract Infection", 
            "Nosocomial Infection", 
            "Bacteriuria"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Bacteriuria", 
                "Urinary Tract Infections", 
                "Cross Infection"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a double blind randomized study with control group. The population is patients in\n      intensive care unit of Shahid Beheshti hospital of Babol city. Main include criteria are\n      18-55 years old, need to having urine catheter for 10 days at least and no urinary infection\n      in catheterization time. Main exclude criteria are appearing genital wound, allergic or\n      dermatitis disorders. Sample size include 105 patients dividing in three equal groups of\n      Povidone-iodine, Chlorhexidine  and Normal saline randomly. Interventions are Washing\n      perinea area and catheter first 5 centimeters by 15 ml of  Povidone-iodine 10%,\n      Chlorhexidine .2%  or Normal saline .9%, 3 times a day for 10 days. Urine analysis are\n      performed in days 1,3,5,7 and 9 after catheterization and urine cultures are performed in\n      days 5 and 10 after catheterization for detection of bacteriuria and microorganism type."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Must need a urinary catheter for 10 days at least\n\n          -  Must have 18-55 years old\n\n          -  Men subjects must doing circumcision already\n\n          -  Urinary catheter must be apply in a standard method by researcher or via her\n             supervision\n\n        Exclusion Criteria:\n\n          -  No more tendency of patient or his/her significant other for continuing study\n\n          -  Malignant disease such as prostate or uterine cancer\n\n          -  History of recurrent urinary infection\n\n          -  Congenital urinary system disorders\n\n          -  history of allergy\n\n          -  Immunodeficiency disorders\n\n          -  Urinary system intervention in past sixth months\n\n          -  Urinary infection at study start\n\n          -  Positive urine analysis or urine culture results in first 3 days of study\n\n          -  Abdominal or pelvic surgery\n\n          -  Women having period during study\n\n          -  Any allergic reaction or dermatitis resulted from applying study solutions\n\n          -  Appearing genital wounds\n\n          -  Diabetes mellitus\n\n          -  Wound in genital area\n\n          -  Discharging, transferring or dying in first week of study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "55 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "105", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 7, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02032394", 
            "org_study_id": "MUMS910212"
        }, 
        "intervention": [
            {
                "arm_group_label": "Povidone-Iodine", 
                "description": "15 ml 10%, 3 imes a day for 10 days /external use for Washing perinea area and catheter first 5 centimeters", 
                "intervention_name": "Povidone-iodine", 
                "intervention_type": "Drug", 
                "other_name": "Betadine"
            }, 
            {
                "arm_group_label": "Chlorhexidine", 
                "description": "15 ml .2%, 3 imes a day for 10 days /external use for Washing perinea area and catheter first 5 centimeters", 
                "intervention_name": "Chlorhexidine", 
                "intervention_type": "Drug", 
                "other_name": "CHLORHEXIDINE GLUCONATE"
            }, 
            {
                "arm_group_label": "Normal saline", 
                "description": "15 ml .9%, 3 imes a day for 10 days /external use for Washing perinea area and catheter first 5 centimeters", 
                "intervention_name": "Normal saline", 
                "intervention_type": "Drug", 
                "other_name": "Chloride  Sodium"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Povidone", 
                "Chlorhexidine", 
                "Chlorhexidine gluconate", 
                "Iodine", 
                "Cadexomer iodine", 
                "Povidone-Iodine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Chlorhexidine", 
            "Povidone-iodine", 
            "bacteriuria", 
            "Urinary Catheterization", 
            "Urinary tract infection"
        ], 
        "lastchanged_date": "January 8, 2014", 
        "location": {
            "contact": {
                "email": "kmohamadnia@gmail.com", 
                "last_name": "Kamran Mohammadnia"
            }, 
            "facility": {
                "address": {
                    "city": "Babol", 
                    "country": "Iran, Islamic Republic of", 
                    "state": "Mazandaran"
                }, 
                "name": "Shahid Beheshti Hospital"
            }, 
            "investigator": {
                "last_name": "Seyedreza Mazloum, Ph.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Iran, Islamic Republic of"
        }, 
        "number_of_arms": "3", 
        "official_title": "Comparison of the Effect of Applying Povidone-iodine and Chlorhexidine Solutions for Perinea Washing on Bacteriuria Rate and Type in Patients With Urinary Catheter in Intensive Care Unit", 
        "overall_contact": {
            "email": "mazlomr@mums.ac.ir", 
            "last_name": "Seyedreza Mazlooum, Head", 
            "phone": "+985118591511"
        }, 
        "overall_official": [
            {
                "affiliation": "Medical Surgical Nursing Department, Mashhad University of Medical Sciences", 
                "last_name": "Seyedreza Mazloum, Ph.D.", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Postgraduate  Department, Mashhad University of Medical Sciences", 
                "last_name": "Kamran Mohammadnia, Ms.", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Medical Surgical Nursing Department, Mashhad University of Medical Sciences", 
                "last_name": "Tayyebe Pourghaznein, Ms.", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Anesthesia Department, Babol University of medical scienses", 
                "last_name": "Ebrahim Alijanpoor, Specialist", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Iran: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Bacteriuria is assessed according to result of urine analysis and is presented as positive or negative.", 
                "measure": "Bacteriuria day 1", 
                "safety_issue": "Yes", 
                "time_frame": "day 1 after urinary catheterizatiion"
            }, 
            {
                "description": "Bacteriuria is assessed according to result of urine analysis and is presented as positive or negative.", 
                "measure": "Bacteriuria day 3", 
                "safety_issue": "Yes", 
                "time_frame": "Day 3 after catheterization"
            }, 
            {
                "description": "Bacteriuria is assessed according to result of urine analysis and is presented as positive or negative.", 
                "measure": "Bacteriuria day 5", 
                "safety_issue": "Yes", 
                "time_frame": "day 5 after catheterization"
            }, 
            {
                "description": "Bacteriuria is assessed according to result of urine analysis and is presented as positive or negative.", 
                "measure": "Bacteriuria day 7", 
                "safety_issue": "Yes", 
                "time_frame": "Day 7 after catheterization"
            }, 
            {
                "description": "Bacteriuria is assessed according to result of urine analysis and is presented as positive or negative.", 
                "measure": "Bacteriuria day 9", 
                "safety_issue": "Yes", 
                "time_frame": "Day 9 after cathetrization"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02032394"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Mashhad University of Medical Sciences", 
            "investigator_full_name": "Seyedreza Mazloum", 
            "investigator_title": "Faculty member of Medical Surgical Nursing Department", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Microorganism type is assessed according to result of Urine culture and is presented as the name of microorganism causing urinary infection.", 
                "measure": "Microorganism Type day 5", 
                "safety_issue": "Yes", 
                "time_frame": "Days 5 after catheterization"
            }, 
            {
                "description": "Microorganism type is assessed according to result of Urine culture and is presented as the name of microorganism causing urinary infection.", 
                "measure": "Microorganism type day 10", 
                "safety_issue": "Yes", 
                "time_frame": "Day 10 after catheterization"
            }
        ], 
        "source": "Mashhad University of Medical Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mashhad University of Medical Sciences", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}